Pure Global AI
ANVISA registration 80115310129Valid until Aug 31, 2034

ANTI-HUMAN GLOBULIN (COOMBS)

ANVISA Registration Number: 80115310129KOVALENT DO BRASIL LTDALORNE LABORATORIES LTDRisk Class III
Verified
Device names
Technical name
ANTI-HUMAN GLOBULIN (COOMBS)
View exact technical-name matches →
PT: GLOBULINA ANTI-HUMANA (COOMBS)
Commercial name
Família COOMBS
View exact commercial-name matches →
Risk class
Class III
Registration details
Registration Number
80115310129
Process Number
25351825926200858
CNPJ
04842199000156
Company information
Registration Holder
KOVALENT DO BRASIL LTDA
Manufacturer
LORNE LABORATORIES LTD
Manufacturing Country
United Kingdom
PT: REINO UNIDO
Dates and status
Publication Date
Aug 31, 2009
Validity
31/08/2034
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for ANTI-HUMAN GLOBULIN (COOMBS) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80115310129 and manufactured by LORNE LABORATORIES LTD. The registration is held by KOVALENT DO BRASIL LTDA with validity until Aug 31, 2034.

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.